Piperacillin/tazobactam and risk of acute kidney injury in adults hospitalized with infection without vancomycin: a multi-centre real-world data analysis
Guobin Su(Guangzhou University of Chinese Medicine), Fan Fan Hou(Southern Medical University), Hua Li(Sir Run Run Shaw Hospital), Guisen Li(China Pharmaceutical University), Yan Zha(Guizhou University), Sheng Nie(Nanfang Hospital), Qingqing Cai(Fudan University), Ying Hu(Harbin Institute of Technology), Yue Cao(Anhui Medical University), Peiyan Gao(Nanfang Hospital), Ying Tang(University of California, Irvine Medical Center), Xin Xu(Nanfang Hospital), Fuhua Lu(Guangzhou University of Chinese Medicine), Jialu Liu(Guangdong Medical College), David W. Johnson(Hennepin County), Chunbo Chen(Southern University of Science and Technology), Qijun Wan(Shenzhen Second People's Hospital), Bi‐Cheng Liu(Nanfang Hospital), Di Xie(Xuzhou Medical College), Gang Xu(University of Michigan), Cuixia Xiao(Guangzhou University of Chinese Medicine), Hong Xu(Anhui Medical University), Jie Shen(Xinjiang Medical University), Xusheng Liu(First Hospital of Lanzhou University), Yaozhong Kong(First People's Hospital of Foshan), Qiongqiong Yang(Sun Yat-sen University), Yilun Zhou(Capital Medical University), Yongjun Shi(Huizhou Central People's Hospital), Jianping Weng(University of Science and Technology of China)
Cited by 16
Related Papers
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k
Prevalence of Diabetes among Men and Women in China
|New England Journal of Medicine|2010|3.1k
Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
|Pharmacological Reviews|2021|1.1k